Literature DB >> 3086903

Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons.

J A Nielsen, N J Shannon, L Bero, K E Moore.   

Abstract

Acute administration of bupropion (10 or 30 mg/kg) to rats increased locomotor activity in a dose-related manner. The highest dose increased the dopamine (DA) concentration while both doses reduced the concentration of dihydroxyphenylacetic acid (DOPAC) in the striatum. The enhancement of locomotor activity and the decrease of striatal DOPAC concentrations were increased with chronic administration (up to 40 days) of bupropion. The rate of DA synthesis in the striatum was increased by the acute administration of d-amphetamine but was not altered by acute or chronic administration of bupropion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086903     DOI: 10.1016/0091-3057(86)90413-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  13 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

3.  Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-03-01       Impact factor: 4.530

4.  Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics.

Authors:  Bruce E Blough; Antonio Landavazo; John S Partilla; Michael H Baumann; Ann M Decker; Kevin M Page; Richard B Rothman
Journal:  ACS Med Chem Lett       Date:  2014-04-15       Impact factor: 4.345

5.  Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.

Authors:  F Ivy Carroll; Bruce E Blough; S Wayne Mascarella; Hernán A Navarro; J Brek Eaton; Ronald J Lukas; M Imad Damaj
Journal:  J Med Chem       Date:  2010-11-08       Impact factor: 7.446

6.  Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.

Authors:  Theodore Kazan; Christopher L Robison; Nicole Cova; Victoria M Madore; Sergios Charntikov
Journal:  Behav Brain Res       Date:  2020-02-25       Impact factor: 3.332

7.  Effects of bupropion on the ejaculatory response of male rats.

Authors:  M E Hueletl-Soto; M Carro-Juárez; G Rodríguez-Manzo
Journal:  Int J Impot Res       Date:  2014-05-01       Impact factor: 2.896

8.  The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats.

Authors:  S Charntikov; A M Falco; K Fink; L P Dwoskin; R A Bevins
Journal:  Neuropharmacology       Date:  2016-10-17       Impact factor: 5.250

9.  A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.

Authors:  D J Heal; A T Frankland; J Gosden; L J Hutchins; M R Prow; G P Luscombe; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Effect of bupropion on nicotine self-administration in rats.

Authors:  Anthony S Rauhut; Nicole Neugebauer; Linda P Dwoskin; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2003-06-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.